相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neutrophils dominate in opsonic phagocytosis of P. falciparum blood-stage merozoites and protect against febrile malaria
Asier Garcia-Senosiain et al.
COMMUNICATIONS BIOLOGY (2021)
Peripheral Merozoite Surface Proteins Are Targets of Naturally Acquired Immunity against Malaria in both India and Ghana
Asier Garcia-Senosiain et al.
INFECTION AND IMMUNITY (2020)
Breadth of Functional Antibodies Is Associated With Plasmodium falciparum Merozoite Phagocytosis and Protection Against Febrile Malaria
Ikhlaq Hussain Kana et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Measuring malaria morbidity in an area of seasonal transmission: Pyrogenic parasitemia thresholds based on a 20-year follow-up study
Marion Dollat et al.
PLOS ONE (2019)
IgM in human immunity to Plasmodium falciparum malaria
M. J. Boyle et al.
SCIENCE ADVANCES (2019)
Cytophilic Antibodies Against Key Plasmodium falciparum Blood Stage Antigens Contribute to Protection Against Clinical Malaria in a High Transmission Region of Eastern India
Ikhlaq Hussain Kana et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparum
Susheel K. Singh et al.
MICROBIAL CELL FACTORIES (2018)
The GMZ2 malaria vaccine: from concept to efficacy in humans
Michael Theisen et al.
EXPERT REVIEW OF VACCINES (2017)
Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria
Ikhlaq Hussain Kana et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Protection against Plasmodium falciparum malaria by PfSPZ Vaccine
Judith E. Epstein et al.
JCI INSIGHT (2017)
Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
Bright Adu et al.
MALARIA JOURNAL (2016)
A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children
Sodiomon B. Sirima et al.
VACCINE (2016)
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
D. E. Neafsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antibody-Dependent Cellular Inhibition Is Associated With Reduced Risk Against Febrile Malaria in a Longitudinal Cohort Study Involving Ghanaian Children
Regis W. Tiendrebeogo et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Fever and the thermal regulation of immunity: the immune system feels the heat
Sharon S. Evans et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria
Faith H. A. Osier et al.
BMC MEDICINE (2014)
Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications
Amed Ouattara et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
The Malaria Vaccine Candidate GMZ2 Elicits Functional Antibodies in Individuals From Malaria Endemic and Non-Endemic Areas
Micha Phill Gronholm Jepsen et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria
Linda M. Murungi et al.
VACCINE (2013)
Changing Malaria Epidemiology and Diagnostic Criteria for Plasmodium falciparum Clinical Malaria
Clementine Roucher et al.
PLOS ONE (2012)
Efficient Measurement of Opsonising Antibodies to Plasmodium falciparum Merozoites
Danika L. Hill et al.
PLOS ONE (2012)
A Field Trial to Assess a Blood-Stage Malaria Vaccine
Mahamadou A. Thera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children
Sabine Belard et al.
PLOS ONE (2011)
Pre-Clinical Assessment of Novel Multivalent MSP3 Malaria Vaccine Constructs
Gilles Bang et al.
PLOS ONE (2011)
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2-A GLURP-MSP3 fusion protein malaria vaccine candidate
Susana Lousada-Dietrich et al.
VACCINE (2011)
Detecting signatures of balancing selection to identify targets of anti-parasite immunity
Gareth D. Weedall et al.
TRENDS IN PARASITOLOGY (2010)
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon
Benjamin Mordmueller et al.
VACCINE (2010)
Protection against a Malaria Challenge by Sporozoite Inoculation.
Meta Roestenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
Bernhards R. Ogutu et al.
PLOS ONE (2009)
The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria
A. A. Holder
PARASITOLOGY (2009)
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali
Issaka Sagara et al.
VACCINE (2009)
Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan
Nnaemeka C. Iriemenam et al.
VACCINE (2009)
Safety and immunogenicity of GMZ2-a MSP3-GLURP fusion protein malaria vaccine candidate
Meral Esen et al.
VACCINE (2009)
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria
Faith H. A. Osier et al.
INFECTION AND IMMUNITY (2008)
Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children
Daniel Dodoo et al.
MALARIA JOURNAL (2008)
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3
Christian Roussilhon et al.
PLOS MEDICINE (2007)
A framework for assessing immunological correlates of protection in vaccine trials
Li Qin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Naturally acquired antibodies to polyrnorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3
F. H. A. Osier et al.
PARASITE IMMUNOLOGY (2007)
Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection
Spencer D. Polley et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and montanide ISA720 Adjuvants
LJM Carvalho et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2005)
Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels
LJM Carvalho et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
A Plasmodium falciparum GLURP-MSP3 chimeric protein;: expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies
M Theisen et al.
VACCINE (2004)
Association between protection, against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendernicity in myanmar: Complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein
S Soe et al.
INFECTION AND IMMUNITY (2004)
Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection
V Meraldi et al.
PARASITE IMMUNOLOGY (2004)
Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls
KE Lyke et al.
INFECTION AND IMMUNITY (2004)
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea
B Genton et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Specificity of the protective antibody response to apical membrane antigen 1
AN Hodder et al.
INFECTION AND IMMUNITY (2001)
Conservation and heterogeneity of the glutamate-rich protein (GLURP) among field isolates and laboratory lines of Plasmodium faliparum
K de Stricker et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal
C Oeuvray et al.
INFECTION AND IMMUNITY (2000)
Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria
D Dodoo et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
